Cargando…
Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies
Polycomb group (PcG) proteins regulate the expression of target genes by modulating histone modifications and are representative epigenetic regulators that maintain the stemness of embryonic and hematopoietic stem cells. Histone methyltransferases enhancer of zeste homolog 1 and 2 (EZH1/2), which ar...
Autores principales: | Nakagawa, Makoto, Kitabayashi, Issay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113435/ https://www.ncbi.nlm.nih.gov/pubmed/29845708 http://dx.doi.org/10.1111/cas.13655 |
Ejemplares similares
-
Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma
por: Nakagawa, Makoto, et al.
Publicado: (2018) -
Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer
por: Shi, Bin, et al.
Publicado: (2019) -
Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma
por: JIA, NAN, et al.
Publicado: (2014) -
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
por: Zhou, X., et al.
Publicado: (2018) -
Enhancer of zeste homolog 2 enhances the migration and chemotaxis of dental mesenchymal stem cells
por: Ma, Huarui, et al.
Publicado: (2019)